Advertisement

Attendee Demographics

The 2015 demographics will be available several weeks after the Symposium ends.

View the 2013 and 2014 demographics below.

2014 Genitourinary Cancers Symposium (January 30- February 1, 2014, San Francisco, California)

Total Registrants
3,190
Professionals 2,960
Exhibitors 179
Spouse, Guest, Media 50
Domestic Attendees 47%
International Attendees 53%

 

Top 10 Countries

USA 1,404
Germany 274
Canada 170
France 156
United Kingdom 110
Japan 97
Brazil 81
Italy 70
The Netherlands 50
Argentina 45
48 other countries 503
Total Professional Attendees 2,960

 

What is your primary professional role? (Attendees may choose one)

Physician 61%
Other 28%
Researcher 6%
Pharmacist 2%
Biostatistician/Epidemiologist 1%
Nurse 1%
Nurse Practitioner 1%

 

Board Certification or International Equivalent (Attendees may choose up to five)

No Response 32%
Medical Oncology 15%
Not applicable 13%
Urology/Urologic Oncology 11%
Internal Medicine 10%
Other 7%
Hematology 3%
Oncology Nursing 2%
Oncology Pharmacy 1%
Allied Health (e.g. Psychology, Physical Therapy, Social Work, etc.) 1%
Laboratory Research 1%
Pharmacology (Clinical) 1%
Biostatistics/Epidemiology 1%
Pathology 1%
Surgery (including Surgical Oncology and Surgical Specialties) 1%
 

2013 Genitourinary Cancers Symposium (February 14-15, 2013, Orlando, Florida)

 

Total Registrants
2,545
Professionals 2,370
Exhibitors 140
Spouse, Guest, Media 35
Domestic Attendees 54%
International Attendees 46%

 

Top 10 Countries

USA 1,248
Germany 189
Canada 133
France 130
United Kingdom 84
Brazil 60
Argentina 57
Japan 52
Italy 50
The Netherlands 35
44 other countries 362
Total Professional Attendees 2,370

 

What is your primary professional role? (Attendees may choose one)

Physician 61%
Other 27%
Researcher 6%
Biostatistician/Epidemiologist 2%
No Response 1%
Nurse 1%
Nurse Practitioner 1%
Pharmicist 1%

 

Board Certification or International Equivalent (Attendees may choose up to five)

No Response 20%
Medical Oncology 18%
Internal Medicine 12%
Urology/Urologic Oncology 11%
Not Applicable 9%
Other 7%
Radiation Oncology 5%
Hematology 4%
Oncology Pharmacy 2%
Allied Health (e.g. Psychology, Physical Therapy, Social Work, etc.) 2%
Laboratory Research 2%
Pharmacology (Clinical) 2%
Biostatistics/Epidemiology 1%
Gastroenterology 1%
Gynecologic Oncology 1%
Oncology Nursing 1%
Pathology 1%
Pediatrics (including Pediatric Oncology and Pediatric Specialties) 1%
Surgery (including Surgical Oncology and Surgical Specialties) 1%
 

 

Cosponsored by